Reneuron

1

Major Shareholdings

PrintE-mail

The current issued share capital of the Company, including shares issued under its blocklisting facility, is 1,788,827,700 ordinary shares. No shares are held as treasury.

The Directors (together with their families and their family trusts and pension scheme arrangements) in aggregate hold 31,599,927 ordinary shares in the Company, representing 1.767% of the Company's current issued share capital.

27.82% of the issued share capital was not in public hands.

The Company is aware of the following significant (3% or greater) shareholdings in the Company's ordinary shares:

Number of ordinary shares

% of issued share capital

Woodford Investment Management

19.94%

The Wales Life Sciences Investment Fund LP

11.18%

Invesco Limited

8.83%

Abingworth Bioventures VI LP

5.28%

Majedie Asset Management Limited

4.94%

        All of the above information was last updated on Tuesday, 19 August 2014 09:00

©ReNeuron Group plc 2005-2014 All rights reserved

Privacy                Disclaimer